Vitamin D in Multiple Sclerosis-Lessons From Animal Studies

Michaela Tanja Haindl1, Sonja Hochmeister1

  • 1Department of General Neurology, University Clinic of Neurology, Medical University of Graz, Graz, Austria.

Frontiers in Neurology
|November 8, 2021
PubMed

Insights

Vitamin D supplementation shows varied effects on multiple sclerosis (MS) risk and activity. This review examines vitamin D

Area of Science:

  • Neuroimmunology
  • Endocrinology
  • Animal Models in Disease Research

Background:

  • Multiple sclerosis (MS) is a complex central nervous system disorder with unclear mechanisms.
  • Genetic and environmental factors contribute to MS.
  • Vitamin D is investigated as a potential therapeutic and preventive agent for MS.

Purpose of the Study:

  • To review existing studies on vitamin D's effects in animal models of MS.
  • To synthesize recent findings on vitamin D and MS disease mechanisms.
  • To address inconsistent results from clinical trials by examining mechanistic data from animal studies.

Main Methods:

  • Review of literature on vitamin D supplementation in various animal models of MS.
  • Analysis of experimental settings and their impact on study outcomes.
  • Synthesis of mechanistic insights derived from animal studies.

Main Results:

  • Vitamin D serum levels show inconsistent correlations with MS risk and activity in clinical studies.
  • Animal models provide essential, standardized data for understanding disease mechanisms.
  • Different animal models yield varied results regarding vitamin D's efficacy.

Conclusions:

  • Animal models are crucial for elucidating the mechanistic role of vitamin D in MS.
  • Standardized animal studies are necessary to reconcile conflicting clinical findings.
  • Further research using animal models is needed to clarify vitamin D's therapeutic potential in MS.

Related Concept Videos